Patent assignee · US · COMPANY

Agilvax Inc.

3Patents
3Active
3Granted
43Portfolio score

Filing activity: Dec 18, 2016 → Mar 16, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US11040223B2 Compositions and methods related to xCT peptides Chemistry; Metallurgy 0 Active
US11059901B2 Compositions and methods related to xCT antibodies Chemistry; Metallurgy 0 Active
US10588953B2 Compositions and methods related to xCT peptides Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.